about
Alpha(2) adrenoceptors regulate proliferation of human intestinal epithelial cellsProteomic analysis of anaplastic lymphoma cell lines: identification of potential tumour markers.Ex vivo pretreatment with melatonin improves survival, proangiogenic/mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidney.Elaboration and evaluation of alginate foam scaffolds for soft tissue engineering.Cardiac fibroblasts regulate sympathetic nerve sprouting and neurocardiac synapse stabilityIntramyocardial transplantation of mesenchymal stromal cells for chronic myocardial ischemia and impaired left ventricular function: Results of the MESAMI 1 pilot trial.alpha(2B)-Adrenergic receptors activate MAPK and modulate proliferation of primary cultured proximal tubule cells.Transcriptional down-regulation of the human alpha2C-adrenergic receptor by cAMP.High tumorigenic potential of a constitutively active mutant of the cholecystokinin 2 receptor.Evaluation of alginate microspheres for mesenchymal stem cell engraftment on solid organ.Evaluation of polyelectrolyte complex-based scaffolds for mesenchymal stem cell therapy in cardiac ischemia treatment.Sphingosine kinase 1 expressed by endothelial colony-forming cells has a critical role in their revascularization activity.Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction.Multimodal gadolinium oxysulfide nanoparticles: a versatile contrast agent for mesenchymal stem cell labelingNew nanoplatform based on Gd2O2S:Eu3+ core: synthesis, characterization and use for in vitro bio-labellingIntraparenchymal injection of bone marrow mesenchymal stem cells reduces kidney fibrosis after ischemia-reperfusion in cyclosporine-immunosuppressed ratsAlginate scaffolds for mesenchymal stem cell cardiac therapy: influence of alginate composition[Ageing: a matter of heart?]
P50
Q22254614-4885D554-2FB9-48B3-BE66-F953750E4C46Q33238975-F6AF4C6E-6DEB-495F-BB61-F1B6524CB029Q33333234-D31BA680-9356-4544-8A75-03D3B0C5008CQ36303328-35DA5E50-2082-430C-8887-06CFEF3BBF94Q37309358-2CADB470-4091-494F-862C-FB782E4D58D5Q38395633-E1909374-1DC3-401B-B422-20335604A98CQ40740067-B922D715-15E7-4CAC-9986-8D84D04518DDQ40746640-D38A24DC-B346-4F3E-AD90-6A7714304863Q42796314-0FB1F0DB-9B17-49FB-99AE-706D6787AE98Q42933955-3FE20AF1-386A-4038-A818-4C0BA01F7973Q45890702-8AF0BB59-78E8-4A60-92CE-DB951F6D9820Q53571554-324A042D-B3E1-456E-8D43-44A35C3F1711Q54473910-CEF692C8-6C3C-41EF-90EE-C4AAF617967AQ57181526-32D38E9B-0265-4545-8311-B2398BE5BB19Q59926460-B8AEC8A8-E75E-4FED-8E7B-875836F2C8CBQ83963300-24C74C22-2A28-417F-98CA-942FC22E0E1CQ84550753-B2659551-3572-46D8-8EB5-6595C23B25D2Q86713827-94709028-AD46-4976-950B-EC7A856686F1
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Daniel Cussac
@ast
Daniel Cussac
@en
Daniel Cussac
@es
Daniel Cussac
@nl
type
label
Daniel Cussac
@ast
Daniel Cussac
@en
Daniel Cussac
@es
Daniel Cussac
@nl
prefLabel
Daniel Cussac
@ast
Daniel Cussac
@en
Daniel Cussac
@es
Daniel Cussac
@nl
P108
P106
P1153
7003534022
P21
P31
P496
0000-0002-7227-898X